Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global 3D Cell Culture Market Report 2017: Huge Investments in R&D From Life Science Companies - Research and Markets

Research and Markets
Posted on: 13 Sep 17

The "Global 3D Cell culture Market - Growth, Trends and Forecast 2017 - 2022" report has been added to Research and Markets' offering.

Cell culture is a process by which prokaryotic cells or eukaryotic cells are artificially grown outside their natural environment in a laboratory under controlled conditions. 3D cell culture is accepted as a new dimension of cell culture sector in biomedical research field. Research laboratories and institutes, hospitals, and biopharmaceutical and biotechnology companies are adopting 3D cell culture for better outputs and the adoption rate is posed to increase rapidly in the near future.

The huge investment from life science companies in R&D, the development of automated large-scale cell culture systems, a rise in research and development investments, rising need for organ transplantation, use of 3D cell culture models as an alternative tool for in vivo testing and increasing focus on regenerative medicine are key factors propelling the growth of the market. However, the lack of experienced and skilled professionals, budget restrictions for small and medium sized laboratories, lack of consistency in 3D cell culture products and stringent process controls for advanced handling capabilities are turning out to be restraints for the market.

The 3D Cell culture market is segmented on the basis of Technology, Applications and the End user. The Technology segment is further categorized into Extracellular matrices (Scaffolds), Bioreactors, Gels, Scaffold-free platforms, Microchips and others. The Applications segment includes Research, Drug discovery, Tissue engineering, Clinical applications, Stem cell biology and others. By End user, the 3D Cell culture market is segmented into Research laboratories and institutes, Biotechnology and pharmaceutical industries, Hospitals and diagnostic centers and others.

Companies Mentioned:

  • 3D Biomatrix
  • 3D Biotek LLC (U.S.)
  • Becton
  • Dickinson and Company (U.S.)
  • Corning Incorporated (U.S.)
  • Thermo Fisher Scientific (U.S.)
  • Global Cell Solutions Inc
  • InSphero AG (Switzerland)
  • Lonza Group (Switzerland)
  • Nano 3D Biosciences (U.S.)
  • Nanofiber Solutions Incorporation (U.S.)
  • Sigma Aldrich Corporation (U.S.)
  • Reinnervate Ltd (A subsidiary of ReproCELL) (U.K.).

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview and Industry Trends

6. Drivers, Restraints, Opportunities and Challenges Analysis

7. Global Defibrillators Market Segmentation

8. Global Defibrillators Market by Geography - Regional Shares and Forecast

9. Competitive Landscape

10. Company Profiles

11. Analyst Outlook for Investment Opportunities

12. Future Outlook of the Market

For more information about this report visit

View source version on

Business Wire

Last updated on: 13/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.